Company: RGNT
Filing Date: 2025-12-05
Form Type: 6-K
Source: 0001213900-25-118725
Chunk: 1

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-12-05
Form: 6-K
Chunk 1
---
 release announcing the pricing and the
closing of the IPO on December 3, 2025 and December 5, 2025, respectively. Copies of the press releases are furnished herewith as Exhibits
99.1 and 99.2 and incorporated herein by reference.

<div align='center'>1

EXHIBIT INDEX</div>

| Exhibit 
 No.     
 1.1     |     | Underwriting                                                                                     
 Agreement, dated as of December 3, 2025, by and between the Company and ThinkEquity LLC          |
|:--------|:----|:-------------------------------------------------------------------------------------------------|
| 99.1    |     | Press release titled: “Regentis Biomaterials Ltd. Announces Pricing of Initial Public Offering”. |
| 99.2    |     | Press release titled: “Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering”. |

<div align='center'>2

SIGNATURES</div>

Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.

| Date: December 5, 2025 | Regentis Biomaterials Ltd. 
 By:                        | /s/                     
 Dr. Eli Hazum           |
|:-----------------------|:---------------------------|:------------------------|
|                        | Name:                      | Dr. Eli Hazum           |
|                        | Title:                     | Chief Executive Officer |

<div align='center'>3</div>